As of 2025-04-22, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (198.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -982.7%.
The range of the Relative Valuation is (123.58) - (292.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 22.7x | 13.9x |
| Forward P/E multiples | 7.8x - 19.8x | 13.0x |
| Fair Price | (123.58) - (292.57) | (198.34) |
| Upside | -650.0% - -1402.0% | -982.7% |
| Date | P/E |